These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8137244)
1. Camptothecins: from bench research to hospital wards. Potmesil M Cancer Res; 1994 Mar; 54(6):1431-9. PubMed ID: 8137244 [No Abstract] [Full Text] [Related]
2. Novel camptothecin derivatives. Legarza K; Yang LX In Vivo; 2005; 19(1):283-92. PubMed ID: 15796188 [TBL] [Abstract][Full Text] [Related]
4. Clinical development of anticancer agents--a National Cancer Institute perspective. Marsoni S; Wittes R Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870 [No Abstract] [Full Text] [Related]
6. Clinical test methods for antitumor drugs in the U.S.S.R. Garin AM; Lichinitser MR Natl Cancer Inst Monogr; 1977 Mar; (45):227-33. PubMed ID: 337153 [No Abstract] [Full Text] [Related]
7. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it? Jung LL; Zamboni WC Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845 [TBL] [Abstract][Full Text] [Related]
8. The clinical pharmacology of topoisomerase I inhibitors. Abang AM Semin Hematol; 1998 Jul; 35(3 Suppl 4):13-21. PubMed ID: 9779877 [TBL] [Abstract][Full Text] [Related]
9. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Garcia-Carbonero R; Supko JG Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891 [TBL] [Abstract][Full Text] [Related]
10. Experimental models and their clinical correlations. Carter SK; Goldin A Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496 [No Abstract] [Full Text] [Related]
11. The place of pharmacology in cancer medicine. Capizzi RL Semin Oncol; 1977 Jun; 4(2):131-3. PubMed ID: 877598 [No Abstract] [Full Text] [Related]
16. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan). Giovanella BC; Stehlin JS; Hinz HR; Kozielski AJ; Harris NJ; Vardeman DM Int J Oncol; 2002 Jan; 20(1):81-8. PubMed ID: 11743646 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase inhibitors as anticancer agents. Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645 [TBL] [Abstract][Full Text] [Related]
18. [Contribution of experimental research to the chemotherapy of tumors]. Franchi G Cancro; 1973; 26(4):221-3. PubMed ID: 4806177 [No Abstract] [Full Text] [Related]
19. Human tumor cloning: drug sensitivity testing clinical correlations. Alberts DS; Salmon SE; Moon TE Prog Clin Cancer; 1982; 8():147-79. PubMed ID: 6760247 [No Abstract] [Full Text] [Related]
20. [Transferability of animal experiment results to cytostatic chemotherapy on humans]. Karrer K Adv Clin Pharmacol; 1977; 14():89-97. PubMed ID: 596276 [No Abstract] [Full Text] [Related] [Next] [New Search]